Molnupirawir (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Molnupirawir" in Polish language version.

refsWebsite

Global rank Polish rank

2gov.uk

432^nd place

597^th place

2doi.org

2^nd place

6^th place

2nih.gov

4^th place

7^th place

1bbc.com

20^th place

48^th place

1polityka.pl

3,178^th place

56^th place

1europa.eu

68^th place

31^st place

1emory.edu

4,363^rd place

9,712^th place

1go.com

48^th place

179^th place

1merck.com

6,464^th place

5,146^th place

1pulsmedycyny.pl

low place

3,705^th place

bbc.com

JimJ. Reed JimJ., Molnupiravir: First pill to treat Covid gets approval in UK, [w:] BBC News [online], 4 listopada 2021 [dostęp 2021-11-23] (ang.).

doi.org

dx.doi.org

MartM. Toots MartM. i inni, Quantitative Efficacy Paradigms of the Influenza Clinical Drug Candidate EIDD-2801 in the Ferret Model, „Translational Research”, 218, 2020, s. 16–28, DOI: 10.1016/j.trsl.2019.12.002, PMID: 31945316, PMCID: PMC7568909 .
MartM. Toots MartM. i inni, Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia, „Science Translational Medicine”, 11 (515), 2019, s. eaax5866, DOI: 10.1126/scitranslmed.aax5866, PMID: 31645453, PMCID: PMC6848974 .

emory.edu

news.emory.edu

EUA application submitted for COVID-19 antiviral discovered at Emory [online], Emory University, 1 października 2021 [dostęp 2021-11-09] (ang.).

europa.eu

ema.europa.eu

EMA issues advice on use of Lagevrio (molnupiravir) for the treatment of COVID-19 [online], European Medicines Agency, 19 listopada 2021 (ang.).

go.com

abcnews.go.com

JoNelJ. Aleccia JoNelJ., Daily pill to treat COVID could be just months away, [w:] ABC News [online], 29 września 2021 [dostęp 2021-11-05] (ang.).

gov.uk

Summary of Product Characteristics for Lagevrio [online], Medicines & Healthcare Products Regulatory Agency [dostęp 2021-11-05] (ang.).
First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHRA [online], Medicines and Healthcare Products Regulatory Agency [dostęp 2021-11-05] (ang.).

merck.com

Merck and Ridgeback’s Molnupiravir, an Oral COVID-19 Antiviral Medicine, Receives First Authorization in the World [online], Merck Sharp & Dohme [dostęp 2021-11-05] (ang.).

nih.gov

ncbi.nlm.nih.gov

MartM. Toots MartM. i inni, Quantitative Efficacy Paradigms of the Influenza Clinical Drug Candidate EIDD-2801 in the Ferret Model, „Translational Research”, 218, 2020, s. 16–28, DOI: 10.1016/j.trsl.2019.12.002, PMID: 31945316, PMCID: PMC7568909 .
MartM. Toots MartM. i inni, Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia, „Science Translational Medicine”, 11 (515), 2019, s. eaax5866, DOI: 10.1126/scitranslmed.aax5866, PMID: 31645453, PMCID: PMC6848974 .

polityka.pl

PawełP. Walewski PawełP., Już dwie tabletki do walki z covidem. Co je różni i komu mogą pomóc?, [w:] Polityka [online], 7 listopada 2021 [dostęp 2021-11-24] .

pulsmedycyny.pl

Są rekomendacje EMA ws. stosowania molnupirawiru, ale lek nie został jeszcze dopuszczony do obrotu, [w:] Puls Medycyny [online] [dostęp 2021-11-24] .